staurosporine has been researched along with cnf 2024 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Damasy, AK; Gadhe, CG; Hong, SS; Jeong, N; Keum, G; Lee, JH; Pae, AN; Seo, SH | 1 |
1 other study(ies) available for staurosporine and cnf 2024
| Article | Year |
|---|---|
Novel 5,6-disubstituted pyrrolo[2,3-d]pyrimidine derivatives as broad spectrum antiproliferative agents: Synthesis, cell based assays, kinase profile and molecular docking study.
Topics: Antineoplastic Agents; Cell Line, Tumor; Humans; Molecular Docking Simulation; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Receptor, Fibroblast Growth Factor, Type 4; Receptor, TIE-2; Receptor, trkA | 2018 |